Parkwood LLC’s DICE Therapeutics DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-18,052
Closed -$839K – 173
2023
Q2
$839K Buy
18,052
+433
+2% +$15K 0.15% 91
2023
Q1
$505K Buy
+17,619
New +$522K 0.07% 114
2022
Q2
– Sell
-12,417
Closed -$238K – 178
2022
Q1
$238K Buy
+12,417
New +$222K 0.04% 124

Parkwood LLC's DICE Position: Q3 2023 in Review

Parkwood LLC sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 18,052 shares — an estimated $839K sold.

Parkwood LLC first reported a position in DICE in Q1 2022 and held it in 3 quarters. The position peaked at $839K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Parkwood LLC reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Parkwood LLC sold 18,052 DICE Therapeutics shares in Q3 2023, an estimated $839K.
  • Parkwood LLC first reported a position in DICE Therapeutics in Q1 2022 and held it in 3 quarters.
  • Parkwood LLC's DICE Therapeutics position peaked at $839K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.

Based on Parkwood LLC's 13F filing for Q3 2023, filed 14 Nov 2023.